Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Pharmacy leaders call for immediate action in NHS Plan to save the sector

Pharmacy leaders call for immediate action in NHS Plan to save the sector

Urgent funding needed to halt pharmacy closures and  unlock their full potential 

As the government begins working on a 10-year plan to reform the NHS in England, pharmacy leaders have warned that many community pharmacies could disappear within a year without improved funding.

Health secretary Wes Streeting has pledged to turn the NHS into a “neighbourhood health service” as he launches a major consultation about the institution’s next decade.


Streeting is set to invite patients and NHS staff to take part in a “national conversation” to shape the government’s 10-year plan for the service next week.

“If we want to save the things we love about the NHS, then we have to change it," the health secretary said while announcing the consultation on Sunday.

He emphasised that their 10-year health plan aims to completely reshape the NHS, transforming it into a neighbourhood health service "powered by cutting-edge technology that helps us stay healthy and out of hospital."

“We will rebuild the health service around what patients tell us they need," Streeting added.

Members of the public, as well as NHS staff and experts, will be invited to share their experiences, views and ideas for fixing the health service via an online platform, Change.NHS.uk, which will be live until the start of next year, and available via the NHS App.

The public engagement exercise will focus on three shifts in healthcare - hospital to community, analogue to digital, and sickness to prevention.

Paul Rees, chief executive of the National Pharmacy Association (NPA), emphasised the crucial role of  pharmacies in community healthcare, stressing the urgent need for investment in the sector to prevent closures.

He said: “Often the health professionals people know best are their pharmacists. A neighbourhood health service means investing in our amazing community pharmacy network, which is embedded in communities across the country, but the reality is that many pharmacies could be forced to close down before the 10-year plan is even published in spring 2025.

“We hope that government will stabilise the community pharmacy network which has been hit by devastating cuts, and expand pharmacy services to bring care close to patients and their communities.

Rees urged the government to address the financial crisis affecting pharmacies to unlock their full potential.

“While pharmacies are in financial crisis and need urgent funding to halt the terrible round of closures that are having such a damaging effect on patients and their communities, there is a huge opportunity to do so much more.

“We hope the government will take this opportunity to fix the crisis in community pharmacy and unleash their potential to make a real difference to patients – and the rest of the NHS. We stand ready to support ministers in that goal,” he added.

Tase Oputu, Chair of the Royal Pharmaceutical Society (RPS) England, has called on the government to prioritise support for patient access to community pharmacies in the new neighbourhood health service.

“Medicines are a fundamental part of the health service and with increasing prescription volumes, the 10-Year Health Plan must consider how pharmacists can be enabled to support the best use of medicines across the system.

“The government has recognised the huge potential for pharmacist prescribing to enhance patient care and it must now make this a reality. Supporting patient access to community pharmacies should be at the heart of the new neighbourhood health service.”

Oputu noted that pharmacists will be crucial to delivering ambitions around public health and prevention, emphasising the need for read-write access to patient records across care settings.

She called for better support throughout pharmacists' careers, including Protected Learning Time and access to the Learning Support Fund for students.

Furthermore, Oputu stressed the importance of investing in hospital pharmacy, particularly in accelerating the roll-out of electronic prescribing and ensuring aseptic pharmacy sites are fit for the future of personalised medicines.

The RPS will survey its members in England to gather their input and shape its response to the consultation.

She urged pharmacists and pharmacy teams to actively participate in shaping the future of the NHS by sharing their insights.

“I know that members across the country are already doing great work every day. It’s vitally important that pharmacists and pharmacy teams engage with this national conversation and help share their ideas for how the NHS can be ready for the future," Oputu stated.

The Health Secretary is calling on the entire nation to contribute to the government's plans for overhauling the NHS. This consultation is described as the biggest national conversation about the future of the NHS since its birth.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less